BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29228418)

  • 1. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
    Hu YC; Wang AM; Lu JK; Cen R; Liu LL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
    Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
    Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA
    Guo Q; Zhang Q; Lu L; Xu Y
    Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
    Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S; Li K
    BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
    Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
    Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
    Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
    Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
    Liu CN; Zhang HY; Liu CL; Wang CC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer.
    Rui X; Xu Y; Huang Y; Ji L; Jiang X
    Cell Physiol Biochem; 2018; 49(5):1792-1803. PubMed ID: 30231238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOXD-AS1 promotes preeclampsia progression via MAPK pathway.
    Jiang J; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8561-8568. PubMed ID: 30575894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.